Skip to main content
. Author manuscript; available in PMC: 2016 Feb 16.
Published in final edited form as: Clin Infect Dis. 2015 Sep 8;62(2):150–156. doi: 10.1093/cid/civ807

Figure 3.

Figure 3

Rotavirus immunoglobulin A (IgA) seroconversion rates by length of time between administration of monovalent rotavirus vaccine (RV1) and oral poliovirus vaccine (OPV) (disregarding the order of vaccine administration). A, Seroconversion rates by length of time between the first RV1 and OPV doses. B, Seroconversion rates by length of time between second RV1 and OPV doses.